AnalysisNews

VBIO today

$0.52-$0.02 (-4.35%)close Nov 16, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minLeaning Bearish

5 minExpanding

Daily trend turns up above $1.26

Key levels

Resistance$1.04

Resistance$0.57

Latest news & SEC filings

NewsLisa Wolf to leave her three executive roles at Valion Bio on December 11

All VBIO news →

About Tivic Health

Tivic Health Systems develops Entolimod, an engineered TLR5 agonist protein, as a countermeasure for acute radiation syndrome and as supportive treatment for cancer therapy side effects including low neutrophil and platelet counts and mucosal damage. It also holds rights to a follow-on compound called Entolasta. A subsidiary, Velocity Bioworks, runs contract development and manufacturing work and a production site in San Antonio, Texas. Customers include government agencies and outside manufacturing clients.

Based on the company's 10-K filed Mar 30, 2026.

Nasdaq · Healthcare

Valion Bio, Inc. (VBIO)

$0.52-0.02 (-4.35%)
REDUCEGrade: DRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
0.881.251.632.000.52Oct 14Oct 22Oct 30Nov 9
High0.54
Low0.51
Open0.54
Volume112K
Avg Vol239K
VWAP0.52
30d High2.38
30d Low0.50
30d Chg-78.36%

What Is the Price Target for VBIO?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.51Upside: +0.0%Confidence: 20%Method: No Coverage

Is VBIO a Buy or Sell Right Now?

28
Investability Score
REDUCE12-18 months

Thesis

  • •Revenue growing -33.7% YoY with DECLINING trend — consistent growth.

Test your own strategy on VBIO

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on VBIO with SEPT’s own market data.

Start Free Trial →

Is VBIO Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

10

Moat Score

NONE

3/9

Piotroski Score

-2.6

Altman Z-Score

What Is Smart Money Doing with VBIO?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Wolf Lisa GofficerBuy4-Sep 18, 2026
Wolf Lisa GofficerSale2$4.24Sep 18, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

VBIO Growth Story

Revenue YoY

-33.7%

3yr Revenue CAGR

-14.7%

EPS Growth YoY

N/A

FCF Growth YoY

-22.9%

Revenue Trend

DECLINING

Dark Pool Trades for VBIO

PREVIEW

Recent off-exchange (dark pool) prints for VBIO: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
24:57:34$0.562,477$$1KBUY
24:55:57$0.561,414$$787BUY
24:39:37$0.552,000$$1KSELL
24:24:51$0.551,404$$769BUY
23:23:50$0.531,000$$534BUY

5 dark pool trades shown · $$5K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Valion Bio, Inc. (VBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

VBIO — frequently asked questions

What is VBIO stock price today?

Valion Bio, Inc. (VBIO) is at $0.52, down 4.35% (-$0.02) at the Nov 16, 2026 close.

Why is VBIO stock moving today?

Latest VBIO news — Nov 5, 2026: Lisa Wolf to leave her three executive roles at Valion Bio on December 11

Did VBIO beat earnings?

VBIO last reported on Aug 14, 2026: EPS -$54.25 vs -$10200.00 expected — a beat of 99.5%.

What are VBIO support and resistance levels?

Resistance: $0.57, $1.04, $1.26.

What are insiders doing with VBIO?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on VBIO?

Nov 5, 2026: Lisa Wolf to leave her three executive roles at Valion Bio on December 11